Neuland Laboratories [NEULANDLAB] vs Alembic [APLLTD] Detailed Stock Comparison

Neuland Laboratories

NSE
Loading...

Alembic

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Neuland Laboratories wins in 10 metrics, Alembic wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricNeuland LaboratoriesAlembicBetter
P/E Ratio (TTM)103.8630.86Alembic
Price-to-Book Ratio12.003.58Alembic
Debt-to-Equity Ratio10.3124.23Neuland Laboratories
PEG Ratio-1.212.09Neuland Laboratories
EV/EBITDA79.4319.19Alembic
Profit Margin (TTM)13.24%8.84%Neuland Laboratories
Operating Margin (TTM)4.88%12.13%Alembic
EBITDA Margin (TTM)4.88%12.13%Alembic
Return on Equity17.06%11.24%Neuland Laboratories
Return on Assets (TTM)11.93%7.51%Neuland Laboratories
Free Cash Flow (TTM)$1.11B$-4.76BNeuland Laboratories
Dividend Yield0.08%1.09%Alembic
1-Year Return15.30%-22.39%Neuland Laboratories
Price-to-Sales Ratio (TTM)13.762.73Alembic
Enterprise Value$184.68B$197.77BAlembic
EV/Revenue Ratio13.892.90Alembic
Gross Profit Margin (TTM)47.77%76.18%Alembic
Revenue per Share (TTM)$1,037$347Neuland Laboratories
Earnings per Share (Diluted)$137.36$30.67Neuland Laboratories
Beta (Stock Volatility)0.010.47Neuland Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Neuland Laboratories vs Alembic Stock Performance Analysis

Loading Price Chart...

Neuland Laboratories
Alembic
Neuland Laboratories Stock Overview | Alembic Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Neuland Laboratories-0.11%5.14%8.55%13.52%26.58%0.97%
Alembic-1.01%-0.66%-1.24%-5.26%13.60%-10.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Neuland Laboratories15.30%1,040.23%1,108.69%1,904.58%17,615.72%16,792.56%
Alembic-22.39%53.75%-2.68%39.27%1,916.67%1,916.67%

News Based Sentiment: Neuland Laboratories vs Alembic

Neuland Laboratories

News based Sentiment: MIXED

Neuland Laboratories experienced a challenging quarter but is actively investing in future growth through capacity expansion and industry engagement. Analyst forecasts are positive, but current financial performance remains a concern, creating a mixed investment narrative.

View Neuland Laboratories News Sentiment Analysis

Alembic

News based Sentiment: MIXED

Alembic Pharmaceuticals is showing a mixed bag of results this month. While long-term investor returns are strong and the company is maintaining dividend payments, a recent share price decline and slower revenue growth compared to the market create some uncertainty. The analyst meet should provide more clarity.

View Alembic News Sentiment Analysis

Performance & Financial Health Analysis: Neuland Laboratories vs Alembic

MetricNEULANDLABAPLLTD
Market Information
Market Cap i₹186.31B₹186.08B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i35,05376,905
90 Day Avg. Volume i57,44590,896
Last Close₹14,433.00₹937.75
52 Week Range₹10,190.70 - ₹18,100.00₹725.20 - ₹1,303.90
% from 52W High-20.26%-28.08%
All-Time High₹18,100.00 (Dec 02, 2024)₹1,303.90 (Oct 07, 2024)
% from All-Time High-20.26%-28.08%
Growth Metrics
Quarterly Revenue Growth-0.33%0.10%
Quarterly Earnings Growth-0.86%0.15%
Financial Health
Profit Margin (TTM) i0.13%0.09%
Operating Margin (TTM) i0.05%0.12%
Return on Equity (TTM) i0.17%0.11%
Debt to Equity (MRQ) i10.3124.23
Cash & Liquidity
Book Value per Share (MRQ)₹1,188.48₹264.09
Cash per Share (MRQ)₹186.76₹4.25
Operating Cash Flow (TTM) i₹3.44B₹-3,101,700,000
Levered Free Cash Flow (TTM) i₹2.60B₹5.83B
Dividends
Last 12-Month Dividend Yield i0.08%1.09%
Last 12-Month Dividend i₹12.00₹11.00

Valuation & Enterprise Metrics Analysis: Neuland Laboratories vs Alembic

MetricNEULANDLABAPLLTD
Price Ratios
P/E Ratio (TTM) i103.8630.86
Forward P/E i38.8721.76
PEG Ratio i-1.212.09
Price to Sales (TTM) i13.762.73
Price to Book (MRQ) i12.003.58
Market Capitalization
Market Capitalization i₹186.31B₹186.08B
Enterprise Value i₹184.68B₹197.77B
Enterprise Value Metrics
Enterprise to Revenue i13.892.90
Enterprise to EBITDA i79.4319.19
Risk & Other Metrics
Beta i0.010.47
Book Value per Share (MRQ) i₹1,188.48₹264.09

Financial Statements Comparison: Neuland Laboratories vs Alembic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NEULANDLABAPLLTD
Revenue/Sales i₹2.93B₹17.11B
Cost of Goods Sold i₹1.53B₹4.07B
Gross Profit i₹1.40B₹13.03B
Research & Development iN/AN/A
Operating Income (EBIT) i₹142.99M₹2.08B
EBITDA i₹423.45M₹2.87B
Pre-Tax Income i₹175.70M₹1.90B
Income Tax i₹36.70M₹364.80M
Net Income (Profit) i₹139.00M₹1.54B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NEULANDLABAPLLTD
Cash & Equivalents i₹1.32B₹834.80M
Total Current Assets i₹11.39B₹40.88B
Total Current Liabilities i₹4.66B₹24.12B
Long-Term Debt i₹1.09B₹467.70M
Total Shareholders Equity i₹15.25B₹51.90B
Retained Earnings i₹9.95B₹43.94B
Property, Plant & Equipment i₹6.74B₹4.45B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NEULANDLABAPLLTD
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNEULANDLABAPLLTD
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i35,05376,905
Average Daily Volume (90 Day) i57,44590,896
Shares Outstanding i12.83M196.56M
Float Shares i7.19M57.33M
% Held by Insiders i0.38%0.71%
% Held by Institutions i0.25%0.17%

Dividend Analysis & Yield Comparison: Neuland Laboratories vs Alembic

MetricNEULANDLABAPLLTD
Last 12-Month Dividend i₹12.00₹11.00
Last 12-Month Dividend Yield i0.08%1.09%
3-Year Avg Annual Dividend i₹12.00₹13.33
3-Year Avg Dividend Yield i0.20%1.17%
3-Year Total Dividends i₹36.00₹40.00
Ex-Dividend DateJul 18, 2025Jul 29, 2025